Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Sana Biotechnology, Inc. (SANA)

2.3700 +0.0300 (+1.28%)
At close: November 6 at 4:00:00 PM EST
2.3600 -0.0100 (-0.42%)
After hours: November 6 at 7:49:47 PM EST
Trade SANA on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
218,748
205,708
270,832
286,127
272,564
Operating Income
-218,748
-205,708
-270,832
-286,127
-272,564
Net Non Operating Interest Income Expense
4,359
3,848
10,471
9,938
3,762
Other Income Expense
2,567
-42,306
-6,398
-7,066
-674
Pretax Income
-211,822
-244,166
-266,759
-283,255
-269,476
Net Income Common Stockholders
-211,822
-244,166
-266,759
-283,255
-269,476
Diluted NI Available to Com Stockholders
-211,822
-244,166
-266,759
-283,255
-269,476
Basic EPS
-0.75
-0.96
-1.16
-1.46
-1.43
Diluted EPS
-0.75
-0.96
-1.16
-1.46
-1.43
Basic Average Shares
277,393
253,234
230,891
194,541
188,344
Diluted Average Shares
277,393
253,234
230,891
194,541
188,344
Total Operating Income as Reported
-218,748
-250,319
-272,723
-293,141
-272,564
Total Expenses
218,748
205,708
270,832
286,127
272,564
Net Income from Continuing & Discontinued Operation
-211,822
-244,166
-266,759
-283,255
-269,476
Normalized Income
-211,822
-199,555
-264,868
-276,241
-269,476
Interest Income
4,359
3,848
10,471
9,938
3,762
Net Interest Income
4,359
3,848
10,471
9,938
3,762
EBIT
-218,748
-205,708
-270,832
-286,127
-272,564
EBITDA
-207,879
-192,958
-255,332
-268,584
-256,939
Reconciled Depreciation
10,869
12,750
15,500
17,543
15,625
Net Income from Continuing Operation Net Minority Interest
-211,822
-244,166
-266,759
-283,255
-269,476
Total Unusual Items Excluding Goodwill
0
-44,611
-1,891
-7,014
--
Total Unusual Items
0
-44,611
-1,891
-7,014
--
Normalized EBITDA
-207,879
-148,347
-253,441
-261,570
-256,939
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 2/4/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: